Curbing the menace of antimicrobial resistance in developing countries.

Harm Reduction Journal
Chidi Victor NwenekaAnibal Sosa

Abstract

Several reports suggest that antimicrobial resistance is an increasing global problem; but like most pandemics, the greatest toll is in the less developed countries. The dismally low rate of discovery of antimicrobials compared to the rate of development of antimicrobial resistance places humanity on a very dangerous precipice. Since antimicrobial resistance is part of an organism's natural survival instinct, total eradication might be unachievable; however, it can be reduced to a level that it no longer poses a threat to humanity. While inappropriate antimicrobial consumption contributes to the development of antimicrobial resistance, other complex political, social, economic and biomedical factors are equally important. Tackling the menace therefore should go beyond the conventional sensitization of members of the public and occasional press releases to include a multi-sectoral intervention involving the formation of various alliances and partnerships. Involving civil society organisations like the media could greatly enhance the success of the interventions.

References

Jan 1, 1979·Reviews of Infectious Diseases·M Finland
Jul 25, 2000·Emerging Infectious Diseases·P Collignon
Apr 5, 2005·Indian Journal of Medical Sciences·Rashmi SharmaBhuvneshwar Kapoor
Jul 28, 2005·The Journal of Antimicrobial Chemotherapy·Alan P JohnsonGeorgia Duckworth
Apr 11, 2006·Globalization and Health·Ruifang ZhangRichard J Zeckhauser
Jun 1, 2006·The Journal of Antimicrobial Chemotherapy·Nicola A C PotzUNKNOWN London & South East ESBL Project Group
Oct 27, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·U FrankE Tacconelli
Nov 11, 2006·Annual Review of Public Health·Elaine Larson
Oct 24, 2007·Journal of the American Board of Family Medicine : JABFM·Margaret B Planta
Jan 10, 2008·The Journal of Infectious Diseases·Jason R AndrewsUNKNOWN Tugela Ferry Care and Research (TF CARES) Collaboration

❮ Previous
Next ❯

Citations

Jan 18, 2011·The International Journal of Pharmacy Practice·Godeliver A B KagasheLloyd Matowe
Oct 18, 2011·Tropical Medicine & International Health : TM & IH·C E Vialle-ValentinD Ross-Degnan
Jul 28, 2011·Medicinal Research Reviews·Frederick Harris, Lynne Pierpoint
Sep 26, 2015·Journal of the Pediatric Infectious Diseases Society·Kirsty Le DoareMike Sharland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Infection in Developing Countries
Arturo Talavera, Ela M Pérez
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine
Monika AroraAlok Mukhopadhyay
Rural and Remote Health
O A T F Kwapong
© 2022 Meta ULC. All rights reserved